RU2013103209A - ANTI-INFLAMMATORY NEUROPROTECTIVE - Google Patents

ANTI-INFLAMMATORY NEUROPROTECTIVE Download PDF

Info

Publication number
RU2013103209A
RU2013103209A RU2013103209/15A RU2013103209A RU2013103209A RU 2013103209 A RU2013103209 A RU 2013103209A RU 2013103209/15 A RU2013103209/15 A RU 2013103209/15A RU 2013103209 A RU2013103209 A RU 2013103209A RU 2013103209 A RU2013103209 A RU 2013103209A
Authority
RU
Russia
Prior art keywords
inflammatory
neuroprotective
noopept
prolylglycine
phenylacetyl
Prior art date
Application number
RU2013103209/15A
Other languages
Russian (ru)
Inventor
Лариса Петровна Коваленко
Анна Вадимовна Таллерова
Светлана Витальевна Алексеева
Елена Владимировна Шипаева
Рита Ушеровна Островская
Татьяна Александровна Гудашева
Андрей Дмитриевич Дурнев
Original Assignee
Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Российской академии медицинских наук
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Российской академии медицинских наук filed Critical Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Российской академии медицинских наук
Priority to RU2013103209/15A priority Critical patent/RU2013103209A/en
Publication of RU2013103209A publication Critical patent/RU2013103209A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Применение препарата Ноопепт (этиловый эфир N-фенилацетил - L-пролилглицина) в качестве противовоспалительного нейропротективного средства.The use of the drug Noopept (ethyl ester N-phenylacetyl - L-prolylglycine) as an anti-inflammatory neuroprotective agent.

Claims (1)

Применение препарата Ноопепт (этиловый эфир N-фенилацетил - L-пролилглицина) в качестве противовоспалительного нейропротективного средства. The use of the drug Noopept (ethyl ester N-phenylacetyl - L-prolylglycine) as an anti-inflammatory neuroprotective agent.
RU2013103209/15A 2013-01-24 2013-01-24 ANTI-INFLAMMATORY NEUROPROTECTIVE RU2013103209A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2013103209/15A RU2013103209A (en) 2013-01-24 2013-01-24 ANTI-INFLAMMATORY NEUROPROTECTIVE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2013103209/15A RU2013103209A (en) 2013-01-24 2013-01-24 ANTI-INFLAMMATORY NEUROPROTECTIVE

Publications (1)

Publication Number Publication Date
RU2013103209A true RU2013103209A (en) 2014-07-27

Family

ID=51264717

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013103209/15A RU2013103209A (en) 2013-01-24 2013-01-24 ANTI-INFLAMMATORY NEUROPROTECTIVE

Country Status (1)

Country Link
RU (1) RU2013103209A (en)

Similar Documents

Publication Publication Date Title
CL2016002027A1 (en) Cyclopropylamine as an inhibitor of lsd1
DOP2017000078A (en) INDAZOLS REPLACED WITH BENCILO AS INHIBITORS OF BUB1.
IL285553A (en) Use of prg4 as an anti-inflammatory agent
CL2016000153A1 (en) Glioxamide substituted pyrrolamide derivatives and their use as medicines for the treatment of hepatitis b
CL2015003395A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
CL2015000942A1 (en) Compounds of substituted benzene.
CL2015000295A1 (en) Compounds derived from alkylpyrimidine; pharmaceutical composition that includes them; Use for the treatment of viral infections and other diseases.
CL2014002093A1 (en) Piperidinopyrimidine derivative compounds; pharmaceutical composition that includes them; Use in the treatment of viral infections.
CL2015002767A1 (en) Therapeutic compounds and compositions
UA116648C2 (en) FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES
CL2015003019A1 (en) Biaromatic antibacterial derivatives
CL2015002897A1 (en) Bace1 inhibitors
AU2014207408A8 (en) Pharmaceutical compositions comprising nitroxyl donors
MX2015011837A (en) Co-crystals of pyrimethanil and selected dithiine tetracarboximide.
CL2015002180A1 (en) Combination therapy for the treatment of nosocomial pneumonia
DOP2016000064A (en) SUBSTITUTED PHENYLALANINE DERIVATIVES
GT201500143A (en) COMPOSITIONS THAT INCLUDE VORTIOXETINA AND DONEPEZILO CAMPO TECNICO
CY1123408T1 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
PE20150167A1 (en) (R) -NIFURATEL, ITS USE FOR THE TREATMENT OF INFECTIONS AND SYNTHESIS OF (R) AND (S) -NIFURATEL
CL2015003431A1 (en) Pyridone derivatives for the treatment of viral infections and additional diseases
CL2015003460A1 (en) Topical aqueous ophthalmic compositions containing a 1h-indole-1-carboxamide derivative and use thereof for the treatment of an ophthalmic disease
UY35004A (en) STABILIZED AMORFA FORM OF AGOMELATIN, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
BR112016028081A2 (en) NEW COMPOUNDS AS ANTITUBERCULAR AGENTS
RU2013103209A (en) ANTI-INFLAMMATORY NEUROPROTECTIVE
CR20150352A (en) NEW ANTIFUNCTIONAL COMPOSITIONS

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20150312